Clinical Trials Directory

Trials / Terminated

TerminatedNCT02152514

RCT Comparing Analgesia Post-VATS With Epimorph VS Placebo

Randomized Controlled Trial Comparing Post-VATS Analgesia Between Patients With an Intrathecal Injection of Morphine and Sufentanil Versus Placebo.

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Université de Sherbrooke · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine if the administration of a mix of Sufentanil and Morphine in intrathecal is a better analgesia regimen than PCA alone in patient post-VATS.

Detailed description

This study will compare the need for analgesia (Hydromorphone PCA) of two groups of patients post-VATS. The placebo group will only have a PCA for post-operative analgesia, witch is the standard care for patient post-VATS. The experimental group will have a intrathecal injection of a mix of morphine and sufentanil before the induction of anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGIntrathecal Morphine/Sufentanil
DEVICEPCA

Timeline

Start date
2013-04-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2014-06-02
Last updated
2016-01-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02152514. Inclusion in this directory is not an endorsement.